Other News To Note
• MiRagen Therapeutics Inc., of Boulder, Colo., published preclinical data showing microRNA-15 is upregulated in response to ischemic damage and contributes to cardiovascular disease. The research confirms that targeting microRNA-15 can spare cardiomyocytes from death during a heart attack. The data were published in Circulation Research.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter